Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2020 Mar 17;11711:6023-6034. doi: 10.1073/pnas.1920008117.
Show Gene links
Show Anatomy links
Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.
Du X
,
Carvalho-de-Souza JL
,
Wei C
,
Carrasquel-Ursulaez W
,
Lorenzo Y
,
Gonzalez N
,
Kubota T
,
Staisch J
,
Hain T
,
Petrossian N
,
Xu M
,
Latorre R
,
Bezanilla F
,
Gomez CM
.
???displayArticle.abstract???
Despite a growing number of ion channel genes implicated in hereditary ataxia, it remains unclear how ion channel mutations lead to loss-of-function or death of cerebellar neurons. Mutations in the gene KCNMA1, encoding the α-subunit of the BK channel have emerged as responsible for a variety of neurological phenotypes. We describe a mutation (BKG354S) in KCNMA1, in a child with congenital and progressive cerebellar ataxia with cognitive impairment. The mutation in the BK channel selectivity filter dramatically reduced single-channel conductance and ion selectivity. The BKG354S channel trafficked normally to plasma, nuclear, and mitochondrial membranes, but caused reduced neurite outgrowth, cell viability, and mitochondrial content. Small interfering RNA (siRNA) knockdown of endogenous BK channels had similar effects. The BK activator, NS1619, rescued BKG354S cells but not siRNA-treated cells, by selectively blocking the mutant channels. When expressed in cerebellum via adenoassociated virus (AAV) viral transfection in mice, the mutant BKG354S channel, but not the BKWT channel, caused progressive impairment of several gait parameters consistent with cerebellar dysfunction from 40- to 80-d-old mice. Finally, treatment of the patient with chlorzoxazone, a BK/SK channel activator, partially improved motor function, but ataxia continued to progress. These studies indicate that a loss-of-function BK channel mutation causes ataxia and acts by reducing mitochondrial and subsequently cellular viability.
Adzhubei,
Predicting functional effect of human missense mutations using PolyPhen-2.
2013, Pubmed
Adzhubei,
Predicting functional effect of human missense mutations using PolyPhen-2.
2013,
Pubmed
Bailey,
KCNMA1-linked channelopathy.
2019,
Pubmed
Bezanilla,
Inactivation of the sodium channel. I. Sodium current experiments.
1977,
Pubmed
Browne,
Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.
1994,
Pubmed
Corbett,
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.
2016,
Pubmed
,
Xenbase
Coutelier,
A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.
2015,
Pubmed
D'Adamo,
Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function.
1999,
Pubmed
,
Xenbase
Dell'Orco,
Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
2015,
Pubmed
Du,
Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.
2013,
Pubmed
Du,
Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder.
2005,
Pubmed
,
Xenbase
Duarri,
The L450F [Corrected] mutation in KCND3 brings spinocerebellar ataxia and Brugada syndrome closer together.
2013,
Pubmed
Duarri,
Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.
2012,
Pubmed
Edwards,
Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle.
1994,
Pubmed
Figueroa,
Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13).
2011,
Pubmed
,
Xenbase
Figueroa,
KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients.
2010,
Pubmed
,
Xenbase
Gavin,
Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity.
1990,
Pubmed
Gessner,
Molecular mechanism of pharmacological activation of BK channels.
2012,
Pubmed
Heginbotham,
Mutations in the K+ channel signature sequence.
1994,
Pubmed
,
Xenbase
Holland,
Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle.
1996,
Pubmed
Imbrici,
Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.
2007,
Pubmed
,
Xenbase
Irie,
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
2014,
Pubmed
,
Xenbase
Jen,
Calcium channelopathies in the central nervous system.
1999,
Pubmed
Latorre,
Molecular Determinants of BK Channel Functional Diversity and Functioning.
2017,
Pubmed
Li,
De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca2+ sensitivity.
2018,
Pubmed
Li,
Functional Role of Mitochondrial and Nuclear BK Channels.
2016,
Pubmed
Liang,
De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
2019,
Pubmed
Liu,
Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells.
2003,
Pubmed
Makhseed,
Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy.
2004,
Pubmed
Marelli,
Autosomal dominant cerebellar ataxias.
2011,
Pubmed
Miyazaki,
An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
2016,
Pubmed
Murata,
Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection.
2001,
Pubmed
Nascimento,
Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
2016,
Pubmed
Ng,
SIFT: Predicting amino acid changes that affect protein function.
2003,
Pubmed
Olesen,
Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone.
1994,
Pubmed
Ophoff,
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
1996,
Pubmed
Ristori,
Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
2010,
Pubmed
Romano,
Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
2015,
Pubmed
Sato,
Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A.
2005,
Pubmed
Sausbier,
Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency.
2004,
Pubmed
Schmitz-Hübsch,
Scale for the assessment and rating of ataxia: development of a new clinical scale.
2006,
Pubmed
Singh,
Intracellular BK(Ca) (iBK(Ca)) channels.
2012,
Pubmed
Singh,
MitoBK(Ca) is encoded by the Kcnma1 gene, and a splicing sequence defines its mitochondrial location.
2013,
Pubmed
Smets,
First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.
2015,
Pubmed
Srivastava,
BRAT1 mutations present with a spectrum of clinical severity.
2016,
Pubmed
Tabarki,
Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures.
2016,
Pubmed
Tao,
Cryo-EM structure of the open high-conductance Ca2+-activated K+ channel.
2017,
Pubmed
Womack,
Characterization of large conductance Ca2+-activated K+ channels in cerebellar Purkinje neurons.
2002,
Pubmed
Womack,
Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons.
2009,
Pubmed
Xu,
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane.
2002,
Pubmed
Yeşil,
Expanding the Phenotype of Homozygous KCNMA1 Mutations; Dyskinesia, Epilepsy, Intellectual Disability, Cerebellar and Corticospinal Tract Atrophy.
2018,
Pubmed
Zatz,
The 10 autosomal recessive limb-girdle muscular dystrophies.
2003,
Pubmed
Zerr,
Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel.
1998,
Pubmed
,
Xenbase
Zhang,
De novo KCNMA1 mutations in children with early-onset paroxysmal dyskinesia and developmental delay.
2015,
Pubmed
